Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05439265 · ClinicalTrials.gov registry record
EMR Tool Impact on HIT Documentation and Management
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 128
- Enrollment target
NCT05439265 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 128 participants.
The verdict
NCT05439265 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction to heparin products which results in a prothrombotic state. Heparin-induced thrombocytopenia generally occurs several days after the start of unfractionated heparin or low molecular weight heparin and is diagnosed based on clinical presentation, and presence of thrombocytopenia. HIT has an incidence of 0.1% to 5% and if recognized early can help prevent major complications. As of November 2014, the responsibility for documenting heparin allergies in the electronic medical record (EMR) has shifted from the physician/medical resident to the pharmacy resident. The purpose of this study is to compare the number, rate, and appropriateness of heparin allergy documentation in order to help decrease adverse medical events related to heparin.
Interventions
- OTHER Electronic medical record order panel and resident involvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05439265
The ClinicalTrials.gov registry entry for NCT05439265 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic medical record order panel and resident involvement is the first listed.
NCT05439265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05439265 about?
NCT05439265 is a clinical study titled "EMR Tool Impact on HIT Documentation and Management". Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction to heparin products which results in a prothrombotic state. Heparin-induced thrombocytopenia generally occurs several days after the start of unfractionated heparin or low molecular weight heparin and is diagnosed bas...
What is the current status of trial NCT05439265?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2014-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT05439265?
The interventions under investigation include: Electronic medical record order panel and resident involvement (OTHER).
Who is sponsoring clinical trial NCT05439265?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.